Liuzzo G, Patrono C. EMPEROR-Reduced supports the use of SGLT2 inhibitors for the treatment of
patients with heart failure and reduced ejection fraction: Comment on the
EMPEROR-Reduced trial. Eur Heart J 2020 Oct 7. pii: 5918827. doi: 10.1093.
PMID: 33026074